Eric Lang
Hoofd Techniek/Wetenschap/O&O bij CHROMOCELL THERAPEUTICS CORPORATION
Vermogen: 3 723 $ op 30-04-2024
Profiel
Eric Lang is currently the Chief Medical Officer at Chromocell Therapeutics Corp.
He previously worked as the Global Head-Clinical Drug Development Strategists at Labcorp Drug Development, Inc. from 2012 to 2017.
Before that, he was the Vice President-Clinical Research at Javelin Pharmaceuticals, Inc. and the Global Head-Clinical Research & Development at Novartis Consumer Health, Inc. He also served as the Chief Medical Officer at Entera Bio Ltd.
in 2018 and as the Vice President-US Clinical Development at Grünenthal USA, Inc. from 2010 to 2011.
Dr. Lang holds a doctorate degree from Ben-Gurion University of the Negev.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-04-2024 | 2 482 ( 0.04% ) | 3 723 $ | 30-04-2024 |
Actieve functies van Eric Lang
| Bedrijven | Functie | Begin |
|---|---|---|
| CHROMOCELL THERAPEUTICS CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-06-2023 |
Eerdere bekende functies van Eric Lang
| Bedrijven | Functie | Einde |
|---|---|---|
| ENTERA BIO LTD. | Hoofd Techniek/Wetenschap/O&O | 21-09-2018 |
| COVANCE INC. | Corporate Officer/Principal | 01-01-2017 |
Grünenthal USA, Inc.
 Grünenthal USA, Inc. Pharmaceuticals: MajorHealth Technology Grünenthal USA, Inc. is a pharmaceutical company based in Morristown, NJ. The private company manufactures and distributes pharmaceutical products. | Corporate Officer/Principal | 01-01-2011 |
Novartis Consumer Health, Inc.
 Novartis Consumer Health, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Novartis Consumer Health, Inc. manufactures and supplies pharmaceutical products. The company is based in Lincoln, NE. | Hoofd Techniek/Wetenschap/O&O | - |
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Eric Lang
| Ben-Gurion University of the Negev | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ENTERA BIO LTD. | Health Technology |
| CHROMOCELL THERAPEUTICS CORPORATION | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Javelin Pharmaceuticals, Inc.
Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Health Technology |
Novartis Consumer Health, Inc.
Novartis Consumer Health, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Novartis Consumer Health, Inc. manufactures and supplies pharmaceutical products. The company is based in Lincoln, NE. | Health Technology |
Grünenthal USA, Inc.
Grünenthal USA, Inc. Pharmaceuticals: MajorHealth Technology Grünenthal USA, Inc. is a pharmaceutical company based in Morristown, NJ. The private company manufactures and distributes pharmaceutical products. | Health Technology |
